VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 50 filers reported holding VINCERX PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $900,636 | -22.3% | 891,719 | 0.0% | 0.02% | -14.3% |
| Q2 2023 | $1,159,235 | +25.0% | 891,719 | 0.0% | 0.03% | +27.3% |
| Q1 2023 | $927,388 | +2.0% | 891,719 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $909,553 | -40.6% | 891,719 | -19.6% | 0.02% | -45.0% |
| Q3 2022 | $1,530,000 | +42.3% | 1,108,570 | +36.2% | 0.04% | +29.0% |
| Q2 2022 | $1,075,000 | -67.0% | 814,194 | 0.0% | 0.03% | -62.2% |
| Q1 2022 | $3,257,000 | -60.5% | 814,194 | +0.6% | 0.08% | -57.1% |
| Q4 2021 | $8,246,000 | -36.3% | 809,195 | +1.1% | 0.19% | -29.8% |
| Q3 2021 | $12,941,000 | – | 800,295 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $31,231,000 | 10.26% |
| Affinity Asset Advisors, LLC | 543,010 | $10,480,000 | 3.56% |
| ACUTA CAPITAL PARTNERS, LLC | 394,000 | $7,604,000 | 2.74% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $9,650,000 | 2.72% |
| Logos Global Management LP | 480,000 | $9,264,000 | 0.90% |
| Sio Capital Management, LLC | 105,000 | $2,027,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 82,948 | $1,601,000 | 0.31% |
| Monashee Investment Management LLC | 99,999 | $1,930,000 | 0.30% |
| Ikarian Capital, LLC | 438,684 | $8,467,000 | 0.28% |
| RTW INVESTMENTS, LP | 500,000 | $9,650,000 | 0.15% |